Iodine-124: A promising positron emitter for organic PET chemistry

Molecules

Volumn 15, Issue 4, 2010, Pages 2686-2718

  Koehler, Lena ^a   Gagnon, Katherine ^b   McQuarrie, Steve ^b   Wuest, Frank ^b  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Iodine 124; Molecular imaging; Positron emission tomography (PET)

Indexed keywords

ANTIBODY; PEPTIDE; PROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

CHEMISTRY; HALF LIFE TIME; HUMAN; ISOTOPE LABELING; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ANTIBODIES; HALF-LIFE; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; NEOPLASMS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEINS; RADIOPHARMACEUTICALS;

EID: 77951781910     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15042686     Document Type: Review

References (119)

1. Weissleder, R.; Pittet, M.J. Imaging in the era of molecular oncology. Nature 2008, 452, 580-589. (Pubitemid 351483372)
2. Blasberg, R.G. Molecular imaging and cancer. Mol. Cancer Ther. 2003, 2, 335-343.
3. Palladino, F.; Canadé, A.; Bianchi, A.; Lesti, G.; Antoniol, O.M.; Macis, G.; Marano, P. Molecular imaging: state of the art. Rays 2003, 28, 45-61.
4. Phelps, M.E. PET: the merging of biology and imaging into molecular imaging. J. Nucl. Med. 2000, 41, 661-681.
5. Phelps, M.E. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. USA 2000, 97, 9226-9233.
6. Paans, A.M.; van Waarde, A.; Elsinga, P.H.; Willemsen, A.T.; Vaalburg, W. Positron emission tomography: the conceptual idea using a multidisciplinary approach. Methods 2002, 27, 195-207.
7. Willemsen, A.T.; van den Hoff, J. Fundamentals of quantitative PET data analysis. Curr. Pharm. Des. 2002, 16, 1513-1526. (Pubitemid 34693066)
8. van den Hoff, J. Principles of quantitative positron emission tomography. Amino Acids 2005, 29, 341-353. (Pubitemid 41813491)
9. Welch, M.J.; Laforest, R.; Lewis, J.S. Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides. Ernst Schering Res. Found. Workshop 2007; 62, 159-181.
10. McQuade, P.; Rowland, D.J.; Lewis, J.S.; Welch, M.J. Positron-emitting isotopes produced on biomedical cyclotrons. Curr. Med. Chem. 2005, 12, 807-818. (Pubitemid 40394332)
11. Fujibayashi, Y.; Suzuki. K.; Fukumura, T.; Mori, T.; Kasamatsu, S. Non-standard radionuclide production for PET in Japan. Q. J. Nucl. Med. Mol. Imaging 2008, 52, 140-144. (Pubitemid 351721933)
12. Lambrecht, R.M.; Sajjad, M.; Qureshi, M.A.; Al-Yanbawi, S.J. Production of iodine-124. J. Radioanal. Nucl. Chem. Lett. 1988, 127, 143-150.
13. 124I for positron emission tomography. J. Labelled Compd. Rad. 1988, 26, 165-167.
14. 124I and 124Te(d,3n)123I reactions from 7 to 24 MeV. Nucl. Instrum. Meth. B 1993, 79, 909-910.
15. 124I. In Proc. 7th Workshop on Targetry and Target Chemistry, Heidelberg, Germany, June 8-11, 1997; pp. 253-262.
16. 124I. Appl. Radiat. Isot. 2001, 55, 303-308.
17. 124I at a small cyclotron. Appl. Radiat. Isot. 1995, 46, 255-259.
18. 124I and 120gI at a small-sized cyclotron. Appl. Radiat. Isot. 2003, 58, 69-78. (Pubitemid 35453949)
19. Glaser, M.; Mackay, D.B.; Ranicar, A.S.O.; Waters, S.L.; Brady, F.; Luthra, S.K. Improved targetry and production of iodine-124 for PET studies. Radiochim. Acta. 2004, 92, 951-956. (Pubitemid 40065444)
20. 124I]-iodine on an 11 MeV cyclotron. Radiochim. Acta 2006, 94, 213-216.
21. 124I reaction. Appl. Radiat. Isot. 2006, 64, 965-970. (Pubitemid 44119185)
22. 124I. In Proc. 6th Workshop on Targetry and Target Chemistry, Vancouver, Canada, August 17-19, 1995; pp. 84-86.
23. National Nuclear Decay Center, Brookhaven National Lab, 2009, (http://www.nndc.bnl.gov/).
24. 124I. Appl. Radiat. Isot. 2001, 55, 149-156. (Pubitemid 32241029)
25. 124I reaction. In Proc. 6th Workshop on Targetry and Target Chemistry, Vancouver, Canada, August 17-19, 1995; pp. 87-88.
26. 124I at small and medium sized cyclotrons. In Proc. 8th Workshop on Targetry and Target Chemistry, St. Louis, MO, June 23-26, 1999; pp. 131-133.
27. 124I and 64Cu radioisotopes at KIRAMS. In Proc. 11th Workshop on Targetry and Target Chemistry, Cambridge, UK, August 28-31, 2006; pp. 58-62.
28. Zweit, J.; Bakir, M.A.; Ott, R.J.; Sharma, H.L.; Cox, M.; Goodall, R. Excitation functions of proton induced reactions in natural tellurium: Production of no-carrier added iodine-124 for PET applications. In Proc. 4th Workshop on Targetry and Target Chemistry, Villigen, Switzerland, September 9-12, 1991; pp. 76-78.
29. 124I reaction. In Proc. 11th Workshop on Targetry and Target Chemistry, Cambridge, UK, August 28-31, 2006; pp. 90-91.
30. 124I at low and medium sized cyclotrons. Appl. Radiat. Isot. 1997, 48, 267-271. (Pubitemid 27079521)
31. 124I. Appl. Radiat. Isot. 2006, 64, 101-109.
32. 124I. Appl. Radiat. Isot. 2006, 64, 409-413.
33. 124I reaction. Appl. Radiat. Isot. 2007, 65, 407-412.
34. 2 target for radioiodine production. Nucl. Instrum. Meth. A. 2004, 521, 161-170.
35. Kudelin, B.K.; Gromova, E.A.; Gavrilina, L.V.; Solin, L.M. Purification of recovered tellurium dioxide for re-use in iodine radioisotope production. Appl. Radiat. Isot. 2001, 54, 383-386.
36. Runz, A.; Wolber, G.; Eisenhut, M.; Semmler, W. The production of I-121 at the vertical beamline of the MC32NI cyclotron at the DKFZ Heidelberg. In Proc. 9th Workshop on Targetry and Target Chemistry, Turku, Finland, May 23-25, 2002; pp. 64-66.
37. Sheh, Y.; Koziorowski, J.; Balatoni, J.; Lom, C.; Dahl J.R.; Finn, R.D. Low energy cyclotron production and chemical separation of "no carrier added" iodine-124 from a reusable, enriched tellurium-124 dioxide/aluminum oxide solid solution target. Radiochim. Acta 2000, 88, 169-173.
38. 124I reaction. In Proc. 8th Workshop on Targetry and Target Chemistry, St. Louis, MO, 1999; pp. 134-136.
39. Der, B.; Sader, J.; McQuarrie, S.; Wilson, J. Heat modeling of water cooled target plates. Proc. 11th Workshop on Targetry and Target Chemistry, Cambridge. August 28-31, 2006; pp. 20-21.
40. 124I solid cyclotron target. In Proc. 12th Workshop on Targetry and Target Chemistry, Seattle, WA, USA, July 21-24, 2008; p. 44.
41. Avila-Rodriguez, M.A.; Sader, J.A.; McQuarrie, S.A. 3D modeling and simulation of the thermal performance of solid cyclotron targets. Proceedings of the COMSOL Conference, Genoble, France, 23-27 October 2007; pp. 359-363.
42. 124I on an 18/9 MeV cyclotrone. In Proc. 7th International conference on nuclear and radiochemistry. Budapest, Hungary, August 24-29, 2008.
43. Nye, J.A.; Dick, D.W.; Avila-Rodriguez, M.A.; Nickles, R.J. Radiohalogen targetry at the University of Wisconsin. Nucl. Instrum. Meth. B. 2005, 241, 693-696.
44. IAEA Technical Report Series No. 432. Standardized high current solid targets for cyclotron production of diagnostic and therapeutic radionuclides. IAEA: Vienna, Austria, 2004.
45. McCarthy, T.J.; Laforest, R.; Downer, J.B.; Lo, A.-R.; Margenau, W.H.; Hughey, B.; Shefer, R.E.; Klinkowskein, R.E.; Welch, M.J. Investigation of I-124, Br-76, and Br-77 production using a small biomedical cyclotron -Can induction furnaces help in the preparation and separation of targets? In Proc. 8th Workshop on Targetry and Target Chemistry, St. Louis, MO, USA, June 23- 26, 1999; pp. 127-130.
46. Rowland, D.J.; Laforest, R.; McCarthy, T.J.; Hughey, B.J.; Welch, M.J. Conventional and induction furnace distillation procedures for the routine production of Br-76,77 and I-124 on disk and slanted targets. J. Labelled Compd. Rad. 2001, 44, Suppl. 1.
47. 124I production. Appl. Radiat. Isot. 2008, 66, 1281-1286.
48. Al-Yanbawi, S.; Melibari, S.; Al-Otabi, F.; Rahma, S.; Al Jammaz, I. Standardized high current solid Te-124 targets for cyclotron production of diagnostic radionuclides. In Proc. 11th Workshop on Targetry and Target Chemistry, Cambridge, UK, August 28-31, 2006; p. 1.
49. 124Te(p,2n) reaction. Int. J. Appl. Radiat. Isot. 1977, 28, 255-261. (Pubitemid 8093719)
50. 124I for radionuclide therapy and positron emission tomography. Radiochemistry 2005, 47, 460-466.
51. 2 targets. Appl. Radiat. Isot. 2000, 52, 181-184. (Pubitemid 30046980)
52. 124 I. J. Radioanal. Nucl. Chem. Lett. 1996, 213, 253-261. (Pubitemid 126722705)
53. Stevenson, N.R.; Buckley, K.; Gelbart, W.Z.; Hurtado, E.T.; Johnson, R.R.; Ruth, T.J.; Zeisler, S.K.; On-line production of radioiodines with low energy accelerators. In Proc. 6th Workshop on Targetry and Target Chemistry, Vancouver, Cananda, August 17-19, 1995; pp. 82-83.
54. Zyuzin, A.; Johnson, R.; van Lier, E. Production and extraction of radioiodine isotopes using low melting temperature tellurium alloys. In Proc. 11th Workshop on Targetry and Target Chemistry, Cambridge, UK, August 28-31, 2006; pp. 128-129.
55. Johnson, R.R.; Watt, R.; Kovac, B.; Zyuzin, A.; Van Lier, E.; Erdman, K.L.; Gyles, Wm.; Sabaiduc, V.; McQuarrie, S.A.; Wilson, J.; Backhouse, C.; Gelbart, Wm.; Kuo, T. Advances in intense beams, beam delivery, targetry, and radiochemistry at advanced cyclotron systems. Nucl. Instrum. Meth. B. 2007, 261, 803-808. (Pubitemid 47043023)
56. 123I reaction with a low energy cyclotron. J. Radioanal. Chem. 1981, 65, 51-56.
57. Ylimaki, R.J.; Kiselev, M.Y.; Čomor, J.J.; Beyer, G.-J. Development of target delivery and recovery system for commercial production of high purity iodine-124. In Proc. 10th Workshop on Targetry and Target Chemistry, Madison, WI, USA, August 13-15, 2004.
58. Pentlow, K.S.; Graham, M.C.; Lambrecht, R.M.; Cheung, N.-K.V.; Larson, S.M. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med. Phys. 1991, 18, 357-366.
59. Beattie, B.J.; Finn, R.D.; Rowland, D.J.; Pentow, K.S. Quantitative imaging of bromine-76 and yttrium-86 with PET: A method for the removal of spurious activity introduced by cascade gamma rays. Med. Phys. 2003, 30, 2410-2423.
60. 86Y. Nucl. Med. Commun. 2006, 27, 237-245. (Pubitemid 44391811)
61. 76Br with 2D and 3D PET. Phys. Med. Biol. 2002, 47, 3519-3534. (Pubitemid 35214680)
62. Sandström, M.; Tolmachev, V.; Kairemo, K.; Lundqvist, H.; Lubberink, M. Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT. Phys. Med. Biol. 2004, 49, 5419-5432.
63. 76Br. Phys. Med. Biol. 2009, 54, 1503-1531.
64. 131I. J. Nucl. Med. 2006, 47, 1375-1381. (Pubitemid 47544894)
65. 124I imaging on a Philips Gemini dual GS PET/CT system. Eur. J. Nucl. Med. Mol. Imaging 2009, 36, 1037-1048.
66. 124I activity distributions using a clinical PET/CT scanner. J. Nucl. Med. 2004, 45, 1237-1244. (Pubitemid 47611671)
67. Liu, X.; Laforest, R. Quantitative small animal PET imaging with nonconventional nuclides, Nucl. Med. Biol. 2009, 36, 551-559.
68. Adam, M.J.; Wilbur, D.S. Radiohalogens for imaging and therapy. Chem. Soc. Rev. 2005, 34, 153-163.
69. Seevers R.H.; Counsell, R.E. Radioiodination techniques for small organic molecules. Chem. Rev. 1982, 82, 575-590.
70. 124IMIBG. J. Nucl. Med. 2007, 48, 827-836. (Pubitemid 47604985)
71. 18F]FAZA-first small animal PET results. J. Pharm. Pharm. Sci. 2007, 10, 203-211. (Pubitemid 46805722)
72. Zanzonico, P.; O'Donoghue, J.; Chapman, J.D.; Schneider, R.; Cai, S.; Larson, S.D.; Wen, B.X.; Chen, Y.C.; Finn, R.; Ruan, S.T.; Gerweck, L.; Humm, J.; Ling, C. Iodine-124-labeled iodoazomycingalactoside imaging of tumor hypoxia in mice with serial microPET scanning. Eur. J. Nucl. Med. 2004, 31, 117-128. (Pubitemid 38133549)
73. Schneider, R.F.; Engelhardt, E.L.; Stobbe, C.C.; Fenning, M.C.; Chapman, J.D. The synthesis and radiolabeling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class. J. Label. Compd. Radiopharm. 1997, 39, 541-557. (Pubitemid 27270514)
74. Riedl, C.C.; Brader, P.; Zanzonico, P.B.; Chun, Y.S.; Woo, Y.H.; Singh, P.; Carlin, S.; Wen, B.X.; Ling, C.C.; Hricak, H.; Fong, Y.M. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology 2008, 248, 561-570.
75. Riedl, C.C.; Brader, P.; Zanzonico, P.; Reid, V.; Woo, Y.; Wen, B.; Ling, C.C.; Hricak, H.; Fong, Y.; Humm, J.L. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic F-18-MISO and I-124-IAZG PET in the same study cohort. Eur. J. Nucl. Med. 2008, 35, 39-46. (Pubitemid 350234134)
76. Stahlschmidt, A.; Machulla, H.J.; Reischl, G.; Knaus, E.E.; Wiebe, L.I. Radioiodination of 1-(2deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studies. Appl. Radiat. Isot. 2008, 66, 1221-1228. (Pubitemid 352033709)
77. Guenther, I.; Wyer, L.; Knust, E.J.; Finn, R.D.; Koziorowski, J.; Weinreich, R. Radiosynthesis and quality assurance of 5- I-124 Iodo-2 '-deoxyuridine for functional PET imaging of cell proliferation. Nucl. Med. Biol. 1998, 25, 359-365. (Pubitemid 28219099)
78. Blasberg, R.G.; Roelcke, U.; Weinreich, R.; Beattie, B.; von Ammon, K.; Yonekawa, Y.; Landolt, H.; Guenther, I.; Crompton, N.E.A.; Vontobel, P.; Missimer, J.; Maguire, R.P.; Koziorowski, J.; Knust, E.J.; Finn, R.D.; Leenders, K.L. Imaging brain tumor proliferative activity with I-124 iododeoxyuridine. Cancer Res. 2000, 60, 624-635. (Pubitemid 30094560)
79. Kim, S.W.; Park, J.H.; Yang, S.D.; Hur, M.G.; Choi, C.W.; Yu, K.R. Synthesis and in vitro/vivo Evaluation of Iodine-123/124 Labelled Hypericin Derivatives. Bull. Korean Chem. Soc. 2008, 29, 2023-2025.
80. Tjuvajev, J.G.; Finn, R.; Watanabe, K.; Joshi, R.; Oku, T.; Kennedy, J.; Beattie, B.; Koutcher, J.; Larson, S.; Blasberg, R.G. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res. 1996, 56, 4087-4095. (Pubitemid 26304995)
81. Doubrovin, M.; Ponomarev, V.; Beresten, T.; Balatoni, J.; Bornmann, W.; Finn, R.; Humm, J.; Larson, S.; Sadelain, M.; Blasberg, R.; Tjuvajev, J.G. Imaging transcriptional regulation of p53dependent genes with positron emission tomography in vivo. Proc. Natl. Acad. Sci. USA 2001, 98, 9300-9305. (Pubitemid 32743911)
82. Brust, P.; Haubner, R.; Friedrich, A.; Scheunemann, M.; Anton, M.; Koufaki, O.N.; Hauses, M.; Noll, S.; Noll, B.; Haberkorn, U.; Schackert, G.; Schackert, H.K.; Avril, N.; Johannsen, B. Comparison of F-18 FHPG and I-124/125 FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur. J. Nucl. Med. 2001, 28, 721-729. (Pubitemid 32477317)
83. Tjuvajev, J.G.; Avril, N.; Oku, T.; Sasajima, T.; Miyagawa, T.; Joshi, R.; Safer, M.; Beattie, B.; DiResta, G.; Daghighian, F.; Augensen, F.; Koutcher, J.; Zweit, J.; Humm, J.; Larson, S.M.; Finn, R.; Blasberg, R. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998, 58, 4333-4341. (Pubitemid 28450034)
84. Akgun, E.; Portoghese, P.S.; Sajjad, M.; Nabi, H.A. Synthesis and I-124-labeling of miodophenylpyrrolomorphinan as a potential PET imaging agent for delta opioid (DOP) receptors. J. Label. Compd. Radiopharm. 2007, 50, 165-170. (Pubitemid 46750662)
85. Pal, A.; Glekas, A.; Doubrovin, M.; Balatoni, J.; Beresten, T.; Maxwell, D.; Soghomonyan, S.; Shavrin, A.; Ageyeva, L.; Finn, R.; Larson, S.M.; Bornmann, W.; Gelovani, J.G. Molecular imaging of EGFR kinase activity in tumors with I-124-labeled small molecular tracer and positron emission tomography. Mol. Imaging Biol. 2006, 8, 262-277. (Pubitemid 44446020)
86. Mishani, E.; Abourbeh, G.; Rozen, Y.; Jacobson, O.; Laky, D.; Ben-David, I.; Levitzki, A.; Shaul, M. Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors. Nucl. Med. Biol. 2004, 31, 469-476. (Pubitemid 38490746)
87. Ortu, G.; Ben-David, I.; Rozen, Y.; Freedman, N.M.T.; Chisin, R.; Levitzki, A.; Mishani, E. Labeled EGFr-TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug. Int. J. Cancer 2002, 101, 360-370. (Pubitemid 34983192)
88. Shaul, M.; Abourbeh, G.; Jacobson, O.; Rozen, Y.; Laky, D.; Levitzki, A.; Mishani, E. Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer. Bioorg. Med. Chem. 2004, 12, 3421-3429. (Pubitemid 38746846)
89. Pandey, S.K.; Sajjad, M.; Chen, Y.H.; Pandey, A.; Missert, J.R.; Batt, C.; Yao, R.T.; Nabi, H.A.; Oseroff, A.R.; Pandey, R.K. Compared to Purpurinimides, the Pyropheophorbide Containing an Iodobenzyl Group Showed Enhanced PDT Efficacy and Tumor Imaging (I-124-PET) Ability. Bioconjug. Chem. 2009, 20, 274-282.
90. Veach, D.R.; Namavari, M.; Beresten, T.; Balatoni, J.; Minchenko, M.; Djaballah, H.; Finn, R.D.; Clarkson, B.; Gelovani, J.G.; Bornmann, W.G.; Larson, S.M. Synthesis and in vitro examination of I-124 -, I-125 - and I-131 -2-(4-iodophenylamino) pyrido 2,3-d pyrimidin-7-one radiolabeled Abl kinase inhibitors. Nucl. Med. Biol. 2005, 32, 313-321.
91. Berding, G.; Schneider, U.; Gielow, P.; Buchert, R.; Donnerstag, F.; Brandau, W.; Knapp, W.H.; Emrich, H.M.; Muller-Vahl, K. Feasibility of central cannabinoid CB1 receptor imaging with I124 AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res. 2006, 147, 249-256. (Pubitemid 44397467)
92. Koehler, L.; Graf, F.; Bergmann, R.; Steinbach, J.; Pietzsch, J.; Wuest, F. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors. Eur. J. Med. Chem. 2010, 45, 727-737.
93. Toogood, P.L.; Harvey, P.J.; Repine, J.T.; Sheehan, D.J.; VanderWel, S.N.; Zhou, H.R.; Keller, P.R.; McNamara, D.J.; Sherry, D.; Zhu, T.; Brodfuehrer, J.; Choi, C.; Barvian, M.R.; Fry, D.W. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. J. Med. Chem. 2005, 48, 2388-2406. (Pubitemid 40516432)
94. VanderWel, S.N.; Harvey, P.J.; McNamara, D.J.; Repine, J.T.; Keller, P.R.; Quin, J.; Booth, R.J.; Elliott, W.L.; Dobrusin, E.M.; Fry, D.W.; Toogood, P.L. Pyrido 2,3-d pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4. J. Med. Chem. 2005, 48, 2371-2387.
95. Graf, F.; Koehler, L.; Kniess, T.; Wuest, F.; Mosch, B.; Pietzsch, J. Cell cycle regulation kinase Cdk4 as a potential target for tumor cell treatment and tumor imaging. J. Oncol. 2009, 106378, 1-12.
96. 124I]IBA-ANNEXIN-V as a potential PET probe for apoptosis. J. Label. Compd. Radiopharm. 2001, 44, S336-S338.
97. Iozzo, P.; Osman, S.; Glaser, M.; Knickmeier, M.; Ferrannini, E.; Pike, V.W.; Camici, P.G.; Law, M.P. In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. Nucl. Med. Biol. 2002, 29, 73-82. (Pubitemid 34088164)
98. Robinson, M.K.; Doss, M.; Shaller, C.; Narayanan, D.; Marks, J.D.; Adler, L.P.; Trotter, D.E.G.; Adams, G.P. Quantitative immuno-positron emission tomography imaging oil HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res. 2005, 65, 1471-1478. (Pubitemid 40270176)
99. Dekker, B.; Keen, H.; Shaw, D.; Disley, L.; Hastings, D.; Hadfield, J.; Reader, A.; Allan, D.; Julyan, P.; Watson, A.; Zweit, J. Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124. Nucl. Med. Biol. 2005, 32, 403-413. (Pubitemid 40692690)
100. Keen, H.G.; Dekker, B.A.; Disley, L.; Hastings, D.; Lyons, S.; Reader, A.J.; Ottewell, P.; Watson, A.; Zweit, J. Imaging apoptosis in vivo using I-124-annexin V and PET. Nucl. Med. Biol. 2005, 32, 395-402. (Pubitemid 40692689)
101. Collingridge, D.R.; Glaser, M.; Osman, S.; Barthel, H.; Hutchinson, O.C.; Luthra, S.K.; Brady, F.; Bouchier-Hayes, L.; Martin, S.J.; Workman, P.; Price, P.; Aboagye, E.O. In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope. Br. J. Cancer. 2003, 89, 1327-1333. (Pubitemid 37363425)
102. Glaser, M.; Collingridge, D.R.; Aboagye, E.O.; Bouchier-Hayes, L.; Hutchinson, O.C.; Martin, S.J.; Price, P.; Brady, F.; Luthra, S.K. Iodine-124 labelled Annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl. Radiat. Isot. 2003, 58, 55-62. (Pubitemid 35453947)
103. Glaser, M.; Brown, D.J.; Law, M.P.; Iozzo, P.; Waters, S.L.; Poole, K.; Knickmeier, M.; Camici, P.G.; Pike, V.W. Preparation of no-carrier-added I-124 A(14)-iodoinsulin as a radiotracer for positron emission tomography. J. Label. Compd. Radiopharm. 2001, 44, 465-480. (Pubitemid 32587782)
104. Dekker, B.; Keen, H.; Lyons, S.; Disley, L.; Hastings, D.; Reader, A.; Ottewell, P.; Watson, A.; Zweit, J. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET. Nucl. Med. Biol. 2005, 32, 241-252. (Pubitemid 40488381)
105. Verel, I.; Visser, G.W.M.; Boerman, O.C.; van Eerd, J.E.M.; Finn, R.; Boellaard, R.; Vosjan, M.; Walsum, M.S.V.; Snow, G.B.; van Dongen, G. Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET. Cancer Biother. Radiopharm. 2003, 18, 655-661. (Pubitemid 37082386)
106. Verel, I.; Visser, G.W.M.; Vosjan, M.; Finn, R.; Boellaard, R.; van Dongen, G. High-quality I124-labelled monoclonal antibodies for use as PET scouting agents prior to I-131radioimmunotherapy. Eur. J. Nucl. Med. 2004, 31, 1645-1652. (Pubitemid 40104611)
107. Sundaresan, G.; Yazaki, P.J.; Shively, J.E.; Finn, R.D.; Larson, S.M.; Raubitschek, A.A.; Williams, L.E.; Chatziioannou, A.F.; Gambhir, S.S.; Wu, A.M. I-124-labeled engineered AntiCEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. J. Nucl. Med. 2003, 44, 1962-1969. (Pubitemid 40022142)
108. Daghighian, F.; Pentlow, K.S.; Larson, S.M.; Graham, M.C.; Diresta, G.R.; Yeh, S.D.J.; Macapinlac, H.; Finn, R.D.; Arbit, E.; Cheung, N.K.V. Development of a methode to measure kinetics of radiolabeled monoclonal antibody in human tumor with applications to microdosimetry - Positron emission tomography studies of I-124 labeled 3F8 monoclonalantibody in glioma. Eur. J. Nucl. Med. 1993, 20, 402-409. (Pubitemid 23204615)
109. Larson, S.M.; Pentlow, K.S.; Volkow, N.D.; Wolf, A.P.; Finn, R.D.; Lambrecht, R.M.; Graham, M.C.; Diresta, G.; Bendriem, B.; Daghighian, F.; Yeh, S.D.J.; Wang, G.J.; Cheung, N.K.V. PET scanning of iodine-124-3F8 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J. Nucl. Med. 1992, 33, 2020-2023.
110. Finn, R.; Cheung, N.K.V.; Divgi, C.; St.Germain, J.; Graham, M.; Pentlow, K.; Larson, S.M. Technical challenges associated with the radiolabeling of monoclonal-antibodies utilizing shortlived, positron emitting radionuclides. Int. J. Rad. Appl. Instrum. B 1991, 18, 9-13.
111. Lee, F.T.; Hall, C.; Rigopoulos, A.; Zweit, J.; Pathmaraj, K.; O'Keefe, G.J.; Smyth, F.E.; Welt, S.; Old, L.J.; Scott, A.M. Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody. J. Nucl. Med. 2001, 42, 764-769. (Pubitemid 32453466)
112. Westera, G.; Reist, H.W.; Buchegger, F.; Heusser, C.H.; Hardman, N.; Pfeiffer, A.; Sharma, H.L.; Vonschulthess, G.K.; Mach, J.P. Radioimmuno Positron Emission Tomography with monoclonal-antibodies - a new approach to quantifying in vivo tumor concentrations and biodistribution for radioimmunotherapy. Nucl. Med. Commun. 1991, 12, 429-437.
113. Rubin, S.C.; Kairemo, K.J.A.; Brownell, A.L.; Daghighian, F.; Federici, M.G.; Pentlow, K.S.; Finn, R.D.; Lambrecht, R.M.; Hoskins, W.J.; Lewis, J.L.; Larson, S.M. High-resolution positron emission tomography of human ovarian-cancer in nude rats using I-124 labeled monoclonalantibodies. Gynecol. Oncol. 1993, 48, 61-67. (Pubitemid 23056187)
114. Bakir, M.A.; Eccles, S.A.; Babich, J.W.; Aftab, N.; Styles, J.M.; Dean, C.J.; Ott, R.J. C-ERB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies. J. Nucl. Med. 1992, 33, 2154-2160.
115. Wilson, C.B.; Snook, D.E.; Dhokia, B.; Taylor, C.V.J.; Watson, I.A.; Lammertsma, A.A.; Lambrecht, R.; Waxman, J.; Jones, T.; Epenetos, A.A. Quantitative measurement of monoclonelantibody distribution and blood-flow using positron emission tomography and I-124 in patients with breast cancer. Int. J. Cancer 1991, 47, 344-347.
116. Glaser, M.; Carroll, V.A.; Collingridge, D.R.; Aboagye, E.O.; Price, P.; Bicknell, R.; Harris, A.L.; Luthra, S.K.; Brady, F. Preparation of the iodine-124 derivative of the Bolton-Hunter reagent ( I-124 I-SHPP) and its use for labelling a VEGF antibody as a PET tracer. J. Label. Compd. Radiopharm. 2002, 45, 1077-1090. (Pubitemid 35387709)
117. Collingridge, D.R.; Carroll, V.A.; Glaser, M.; Aboagye, E.O.; Osman, S.; Hutchinson, O.C.; Barthel, H.; Luthra, S.K.; Brady, F.; Bicknell, R.; Price, P.; Harris, A.L. The development of I124 iodinated-VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res. 2002, 62, 5912-5919. (Pubitemid 35204754)
118. Chaturvedi, R.; Heimburg, J.; Yan, J.; Koury, S.; Sajjad, M.; Abdel-Nabi, H.H.; RittenhouseOlson, K. Tumor immunolocalization using I-124-iodine-labeled JAA-F11 antibody to ThomsenFriedenreich alpha-linked antigen. Appl. Radiat. Isot. 2008, 66, 278-287.
119. Koziorowski, J.; Henssen, C.; Weinreich, R. A new convenient route to radioiodinated Nsuccinimidyl 3- and 4-iodobenzoate, two reagents for radioiodination of proteins. Appl. Radiat. Isot. 1998, 49, 955-959. (Pubitemid 28264221)